HEADER TRANSCRIPTION 16-MAY-08 3D5F TITLE CRYSTAL STRUCTURE OF PPAR-DELTA COMPLEX COMPND MOL_ID: 1; COMPND 2 MOLECULE: PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR DELTA; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: LIGAND BINDING DOMAIN, UNP RESIDUES 175-441; COMPND 5 SYNONYM: PPAR-DELTA, PPAR-BETA, NUCLEAR RECEPTOR SUBFAMILY 1 GROUP C COMPND 6 MEMBER 2, NUCLEAR HORMONE RECEPTOR 1, NUC1, NUCI; COMPND 7 ENGINEERED: YES; COMPND 8 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 5 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 6 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 7 EXPRESSION_SYSTEM_PLASMID: PET28 KEYWDS NUCLEAR RECEPTOR, ACTIVATOR, ALTERNATIVE SPLICING, DNA-BINDING, KEYWDS 2 METAL-BINDING, NUCLEUS, TRANSCRIPTION, TRANSCRIPTION REGULATION, KEYWDS 3 ZINC, ZINC-FINGER EXPDTA X-RAY DIFFRACTION AUTHOR Y.AMANO REVDAT 3 10-NOV-21 3D5F 1 REMARK SEQADV REVDAT 2 24-FEB-09 3D5F 1 VERSN REVDAT 1 03-JUN-08 3D5F 0 JRNL AUTH A.IWASHITA,K.MIHARA,Y.AMANO,M.ORITA,N.MATSUOKA JRNL TITL PPAR-DELTA ACTIVATION CONTRIBUTES TO NEUROPROTECTIO AGAINST JRNL TITL 2 THAPSIGARGIN-INDUCED SH-SY5Y CELL DEATH JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 2.20 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.20 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 42.47 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 96.9 REMARK 3 NUMBER OF REFLECTIONS : 33944 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : NULL REMARK 3 FREE R VALUE TEST SET SELECTION : NULL REMARK 3 R VALUE (WORKING SET) : 0.278 REMARK 3 FREE R VALUE : 0.281 REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : NULL REMARK 3 BIN RESOLUTION RANGE LOW (A) : NULL REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : NULL REMARK 3 BIN FREE R VALUE : NULL REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4100 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 58 REMARK 3 SOLVENT ATOMS : 87 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 38.64 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : NULL REMARK 3 BOND ANGLES (DEGREES) : NULL REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL REMARK 3 IMPROPER ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : NULL REMARK 3 BSOL : NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 3D5F COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 20-MAY-08. REMARK 100 THE DEPOSITION ID IS D_1000047614. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 20-DEC-04 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SPRING-8 REMARK 200 BEAMLINE : BL32B2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.000 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : RIGAKU JUPITER 210 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : CRYSTALCLEAR REMARK 200 DATA SCALING SOFTWARE : CRYSTALCLEAR REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 33944 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.200 REMARK 200 RESOLUTION RANGE LOW (A) : 42.470 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 97.1 REMARK 200 DATA REDUNDANCY : 3.840 REMARK 200 R MERGE (I) : 0.12900 REMARK 200 R SYM (I) : 0.12900 REMARK 200 FOR THE DATA SET : 4.4000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.20 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.28 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.2 REMARK 200 DATA REDUNDANCY IN SHELL : 3.81 REMARK 200 R MERGE FOR SHELL (I) : 0.41600 REMARK 200 R SYM FOR SHELL (I) : 0.41600 REMARK 200 FOR SHELL : 1.300 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: PDB ENTRY 1GWX REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 57.01 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.86 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PEG 8000, PH 6.5, VAPOR DIFFUSION, REMARK 280 TEMPERATURE 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 46.41450 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2, 3 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 1370 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 23330 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -15.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 2 -1.000000 0.000000 0.000000 25.99886 REMARK 350 BIOMT2 2 0.000000 1.000000 0.000000 46.41450 REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 95.51062 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 3 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 LYS A 240 REMARK 465 ALA A 241 REMARK 465 SER A 242 REMARK 465 HIS A 243 REMARK 465 THR A 244 REMARK 465 ALA A 245 REMARK 465 LYS A 265 REMARK 465 GLN A 266 REMARK 465 LEU A 267 REMARK 465 VAL A 268 REMARK 465 ASN A 269 REMARK 465 GLY A 270 REMARK 465 TYR A 477 REMARK 465 GLY B 239 REMARK 465 LYS B 240 REMARK 465 ALA B 241 REMARK 465 SER B 242 REMARK 465 HIS B 243 REMARK 465 THR B 244 REMARK 465 ALA B 245 REMARK 465 LYS B 265 REMARK 465 GLN B 266 REMARK 465 LEU B 267 REMARK 465 VAL B 268 REMARK 465 ASN B 269 REMARK 465 GLY B 270 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLU A 462 CG CD OE1 OE2 REMARK 470 SER B 215 OG REMARK 470 LYS B 336 CG CD CE NZ REMARK 470 LYS B 434 CG CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LEU A 237 17.36 -69.72 REMARK 500 THR A 238 91.01 49.15 REMARK 500 LEU A 262 -35.26 -35.26 REMARK 500 VAL A 263 -76.65 -117.56 REMARK 500 TYR A 274 -167.13 -53.84 REMARK 500 LYS A 275 -44.13 170.38 REMARK 500 PRO A 304 -53.00 -28.85 REMARK 500 LEU A 311 -34.04 -39.01 REMARK 500 ALA A 342 72.30 49.22 REMARK 500 ASN A 343 52.64 35.51 REMARK 500 LYS A 358 -50.38 -23.02 REMARK 500 LYS B 232 -41.19 172.73 REMARK 500 ILE B 236 17.73 -66.31 REMARK 500 LEU B 262 52.94 -66.17 REMARK 500 VAL B 263 89.92 -38.51 REMARK 500 LYS B 275 -77.54 -89.23 REMARK 500 PRO B 304 -85.67 -21.01 REMARK 500 LYS B 358 -60.86 -3.85 REMARK 500 GLU B 378 70.91 40.46 REMARK 500 ASN B 402 75.23 -101.67 REMARK 500 LYS B 458 -64.85 -91.09 REMARK 500 GLU B 460 48.45 -86.00 REMARK 500 GLU B 462 -15.39 91.45 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE L41 A 501 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE L41 B 501 DBREF 3D5F A 211 477 UNP Q03181 PPARD_HUMAN 175 441 DBREF 3D5F B 211 477 UNP Q03181 PPARD_HUMAN 175 441 SEQADV 3D5F GLN A 430 UNP Q03181 TYR 394 ENGINEERED MUTATION SEQADV 3D5F GLN B 430 UNP Q03181 TYR 394 ENGINEERED MUTATION SEQRES 1 A 267 LEU LYS ALA PHE SER LYS HIS ILE TYR ASN ALA TYR LEU SEQRES 2 A 267 LYS ASN PHE ASN MET THR LYS LYS LYS ALA ARG SER ILE SEQRES 3 A 267 LEU THR GLY LYS ALA SER HIS THR ALA PRO PHE VAL ILE SEQRES 4 A 267 HIS ASP ILE GLU THR LEU TRP GLN ALA GLU LYS GLY LEU SEQRES 5 A 267 VAL TRP LYS GLN LEU VAL ASN GLY LEU PRO PRO TYR LYS SEQRES 6 A 267 GLU ILE SER VAL HIS VAL PHE TYR ARG CYS GLN CYS THR SEQRES 7 A 267 THR VAL GLU THR VAL ARG GLU LEU THR GLU PHE ALA LYS SEQRES 8 A 267 SER ILE PRO SER PHE SER SER LEU PHE LEU ASN ASP GLN SEQRES 9 A 267 VAL THR LEU LEU LYS TYR GLY VAL HIS GLU ALA ILE PHE SEQRES 10 A 267 ALA MET LEU ALA SER ILE VAL ASN LYS ASP GLY LEU LEU SEQRES 11 A 267 VAL ALA ASN GLY SER GLY PHE VAL THR ARG GLU PHE LEU SEQRES 12 A 267 ARG SER LEU ARG LYS PRO PHE SER ASP ILE ILE GLU PRO SEQRES 13 A 267 LYS PHE GLU PHE ALA VAL LYS PHE ASN ALA LEU GLU LEU SEQRES 14 A 267 ASP ASP SER ASP LEU ALA LEU PHE ILE ALA ALA ILE ILE SEQRES 15 A 267 LEU CYS GLY ASP ARG PRO GLY LEU MET ASN VAL PRO ARG SEQRES 16 A 267 VAL GLU ALA ILE GLN ASP THR ILE LEU ARG ALA LEU GLU SEQRES 17 A 267 PHE HIS LEU GLN ALA ASN HIS PRO ASP ALA GLN GLN LEU SEQRES 18 A 267 PHE PRO LYS LEU LEU GLN LYS MET ALA ASP LEU ARG GLN SEQRES 19 A 267 LEU VAL THR GLU HIS ALA GLN MET MET GLN ARG ILE LYS SEQRES 20 A 267 LYS THR GLU THR GLU THR SER LEU HIS PRO LEU LEU GLN SEQRES 21 A 267 GLU ILE TYR LYS ASP MET TYR SEQRES 1 B 267 LEU LYS ALA PHE SER LYS HIS ILE TYR ASN ALA TYR LEU SEQRES 2 B 267 LYS ASN PHE ASN MET THR LYS LYS LYS ALA ARG SER ILE SEQRES 3 B 267 LEU THR GLY LYS ALA SER HIS THR ALA PRO PHE VAL ILE SEQRES 4 B 267 HIS ASP ILE GLU THR LEU TRP GLN ALA GLU LYS GLY LEU SEQRES 5 B 267 VAL TRP LYS GLN LEU VAL ASN GLY LEU PRO PRO TYR LYS SEQRES 6 B 267 GLU ILE SER VAL HIS VAL PHE TYR ARG CYS GLN CYS THR SEQRES 7 B 267 THR VAL GLU THR VAL ARG GLU LEU THR GLU PHE ALA LYS SEQRES 8 B 267 SER ILE PRO SER PHE SER SER LEU PHE LEU ASN ASP GLN SEQRES 9 B 267 VAL THR LEU LEU LYS TYR GLY VAL HIS GLU ALA ILE PHE SEQRES 10 B 267 ALA MET LEU ALA SER ILE VAL ASN LYS ASP GLY LEU LEU SEQRES 11 B 267 VAL ALA ASN GLY SER GLY PHE VAL THR ARG GLU PHE LEU SEQRES 12 B 267 ARG SER LEU ARG LYS PRO PHE SER ASP ILE ILE GLU PRO SEQRES 13 B 267 LYS PHE GLU PHE ALA VAL LYS PHE ASN ALA LEU GLU LEU SEQRES 14 B 267 ASP ASP SER ASP LEU ALA LEU PHE ILE ALA ALA ILE ILE SEQRES 15 B 267 LEU CYS GLY ASP ARG PRO GLY LEU MET ASN VAL PRO ARG SEQRES 16 B 267 VAL GLU ALA ILE GLN ASP THR ILE LEU ARG ALA LEU GLU SEQRES 17 B 267 PHE HIS LEU GLN ALA ASN HIS PRO ASP ALA GLN GLN LEU SEQRES 18 B 267 PHE PRO LYS LEU LEU GLN LYS MET ALA ASP LEU ARG GLN SEQRES 19 B 267 LEU VAL THR GLU HIS ALA GLN MET MET GLN ARG ILE LYS SEQRES 20 B 267 LYS THR GLU THR GLU THR SER LEU HIS PRO LEU LEU GLN SEQRES 21 B 267 GLU ILE TYR LYS ASP MET TYR HET L41 A 501 29 HET L41 B 501 29 HETNAM L41 {4-[3-(4-ACETYL-3-HYDROXY-2-PROPYLPHENOXY) HETNAM 2 L41 PROPOXY]PHENOXY}ACETIC ACID FORMUL 3 L41 2(C22 H26 O7) FORMUL 5 HOH *87(H2 O) HELIX 1 1 LEU A 211 PHE A 226 1 16 HELIX 2 2 THR A 229 LEU A 237 1 9 HELIX 3 3 ASP A 251 GLY A 261 1 11 HELIX 4 4 GLU A 276 SER A 302 1 27 HELIX 5 5 ILE A 303 LEU A 309 1 7 HELIX 6 6 PHE A 310 ALA A 331 1 22 HELIX 7 7 ARG A 350 LEU A 356 1 7 HELIX 8 8 ARG A 357 ALA A 376 1 20 HELIX 9 9 ASP A 380 LEU A 393 1 14 HELIX 10 10 ASN A 402 HIS A 425 1 24 HELIX 11 11 GLN A 430 GLU A 460 1 31 HELIX 12 12 HIS A 466 TYR A 473 1 8 HELIX 13 13 LEU B 211 PHE B 226 1 16 HELIX 14 14 THR B 229 ARG B 234 1 6 HELIX 15 15 ASP B 251 GLU B 259 1 9 HELIX 16 16 GLU B 276 LYS B 301 1 26 HELIX 17 17 SER B 305 LEU B 309 5 5 HELIX 18 18 PHE B 310 LEU B 330 1 21 HELIX 19 19 ALA B 331 VAL B 334 5 4 HELIX 20 20 ARG B 350 LEU B 356 1 7 HELIX 21 21 ARG B 357 ALA B 376 1 20 HELIX 22 22 ASP B 380 LEU B 393 1 14 HELIX 23 23 ASN B 402 HIS B 425 1 24 HELIX 24 24 GLN B 430 GLU B 460 1 31 HELIX 25 25 HIS B 466 LYS B 474 1 9 SHEET 1 A 4 PHE A 247 ILE A 249 0 SHEET 2 A 4 GLY A 346 THR A 349 1 O PHE A 347 N ILE A 249 SHEET 3 A 4 GLY A 338 VAL A 341 -1 N LEU A 339 O VAL A 348 SHEET 4 A 4 VAL A 334 ASN A 335 -1 N ASN A 335 O GLY A 338 SHEET 1 B 3 PHE B 247 ILE B 249 0 SHEET 2 B 3 GLY B 346 THR B 349 1 O PHE B 347 N ILE B 249 SHEET 3 B 3 GLY B 338 VAL B 341 -1 N LEU B 339 O VAL B 348 SITE 1 AC1 11 TRP A 264 ARG A 284 CYS A 285 THR A 288 SITE 2 AC1 11 THR A 289 HIS A 323 LEU A 330 LEU A 339 SITE 3 AC1 11 HIS A 449 LEU A 469 TYR A 473 SITE 1 AC2 11 TRP B 264 ARG B 284 CYS B 285 THR B 288 SITE 2 AC2 11 THR B 289 HIS B 323 LEU B 330 ILE B 363 SITE 3 AC2 11 HIS B 449 MET B 453 TYR B 473 CRYST1 39.456 92.829 96.454 90.00 98.02 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.025345 0.000000 0.003571 0.00000 SCALE2 0.000000 0.010772 0.000000 0.00000 SCALE3 0.000000 0.000000 0.010470 0.00000